ECOG Trial Outcomes in Smoldering Myeloma

Robert Rifkin, MD, McKesson Biosimilars, Associate Chair, Rocky Mountain Cancer Centers discusses the outcomes from the ECOD trial in smoldering multiple myeloma (MM). <br /> Author: obr Added: 07/01/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts